Outcome of Treating Bladder Cancer in Sohag University Hospital

Completed

• Conditions: Bladder Cancer

• Registration Number: NCT05082818
• Lead Sponsor: Sohag University

Brief Summary

Retrospective study of outcome of urinary bladder cancer treated in Sohag University hospital in the past 5 years from 2016 to 2020

Detailed Description

This study asses the risk factors, prognosis,disease free survival and overall survive rate of treating urinary badder cancer

Study Timeline

• Study First Submitted: 2021-10-15
• Study First Submitted QC: 2021-10-15
• Study First Posted: 2021-10-19
• Study Start: 2021-10-30
• Primary Completion: 2022-05-28
• Study Completion: 2022-05-30
• Status Verified: 2022-06
• Last Update Submitted: 2022-06-12
• Last Update Posted: 2022-06-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 168

Inclusion Criteria

• all stages and grades of urinary bladder cancer Any histological types of urinary bladder cancer

Exclusion Criteria

• presence of other malignancies

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Disease free survival	2 weeks after treatment to the time of relapse	Time from the end of treatment to the date of first relapse

Trial Locations

Locations (1)

Sohag University Hospital; 🇪🇬 Sohag, Egypt